Dupont Capital Management’s Liminatus Pharma Warrants LIMNW Stock Holding History

Dupont Capital Management’s Portfolio LIMNW Stock Details LIMNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$318	Hold	6,250	–	–	0.01%	28
2026 Q1	$306	Hold	6,250	–	–	﹤0.01%	88
2025 Q4	$219	Hold	6,250	–	–	﹤0.01%	91
2025 Q3	$925	Hold	6,250	–	–	﹤0.01%	89
2025 Q2	$1.52K	Buy	+6,250	New	+$1.23K	﹤0.01%	83

Other funds holding LIMNW

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Dupont Capital Management's LIMNW Position: Q2 2026 in Review

Dupont Capital Management held its Liminatus Pharma Warrants (LIMNW) position steady in Q2 2026 at 6,250 shares worth $318. The position accounts for 0.01% of the portfolio, ranked #28.

Dupont Capital Management first reported a position in LIMNW in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.52K in Q2 2025. 2 funds tracked by Wall St. Rank hold LIMNW as of Q2 2026.

Dupont Capital Management held 6,250 shares of Liminatus Pharma Warrants worth $318 as of Q2 2026.
Dupont Capital Management left its Liminatus Pharma Warrants share count unchanged in Q2 2026.
Liminatus Pharma Warrants made up 0.01% of Dupont Capital Management's portfolio in Q2 2026, its #28 holding.
Dupont Capital Management first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 5 quarters since.
Dupont Capital Management's Liminatus Pharma Warrants position peaked at $1.52K in Q2 2025.
2 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q2 2026.

Based on Dupont Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.